May 30, 2018
- FDA alerts health care professionals, patients, and the drug supply chain not to use stolen fertility drugs, Gonal-f RFF Redi-ject and Gonal-f Multi-Dose
- Assessment of Pressor Effects of Drugs Guidance for Industry (PDF - 106KB)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Xeljanz (tofacitinib), a new treatment for moderately to severely active ulcerative colitis
- National Drug Code Directory (updated)
- Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Core Guideline Guidance for Industry (PDF - 451KB)
- Warning Letters 2018 (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario